```html

Aflatoxicosis: A Complete Patient‑Focused Guide

Overview

Aflatoxicosis is a poisoning syndrome that occurs after ingesting foods contaminated with aflatoxins – toxic metabolites produced by certain molds of the genera Aspergillus (most commonly A. flavus and A. parasiticus). Aflatoxins are among the most potent naturally occurring carcinogens and can cause acute liver injury, chronic liver disease, and immunosuppression.

While anyone who eats contaminated food can develop aflatoxicosis, the condition is most prevalent in regions where staple crops (corn, peanuts, tree nuts, and cottonseed) are stored in warm, humid conditions that favor mold growth. Outbreaks are reported especially in sub‑Saharan Africa, parts of Asia, and South America. In the United States, cases are rare (< 1 per 100,000 people) but still occur, typically linked to improperly stored home‑grown nuts or grain.

According to the World Health Organization (WHO), up to 25 % of the global food supply may be contaminated with aflatoxins at levels that pose a health risk, translating to an estimated 4.5 billion people exposed annually [1].

Symptoms

Symptoms differ markedly between acute and chronic exposure. Below is a complete list, grouped by system.

Acute Aflatoxicosis (hours to days after a large dose)

• Nausea and vomiting – often the first sign; may be profuse and contain bile.
• Abdominal pain – usually in the right upper quadrant where the liver resides.
• Loss of appetite – may lead to rapid weight loss.
• Diarrhea – can be watery or contain blood in severe cases.
• Fever – low‑grade to high‑grade, reflecting systemic inflammation.
• Hepatomegaly (enlarged liver) – palpable on physical exam.
• Jaundice – yellowing of the skin and eyes due to impaired bilirubin clearance.
• Ascites – accumulation of fluid in the abdomen in very severe cases.
• Bleeding tendency – easy bruising, nosebleeds, or gastrointestinal hemorrhage due to impaired clotting factor synthesis.
• Encephalopathy – confusion, drowsiness, or seizures in fulminant liver failure.

Chronic Aflatoxicosis (months to years of low‑level exposure)

• Fatigue and weakness – persistent, not relieved by rest.
• Unexplained weight loss.
• Mild right‑upper‑quadrant discomfort or fullness.
• Elevated liver enzymes (AST, ALT, GGT) detected on routine labs.
• Progressive jaundice – may develop slowly.
• Hepatocellular carcinoma (HCC) – a serious long‑term complication; early symptoms are often vague (abdominal mass, pain, weight loss).
• Immunosuppression – increased susceptibility to infections, especially respiratory and gastrointestinal.

Causes and Risk Factors

Primary Cause

Aflatoxins are produced when Aspergillus molds colonize crops under specific environmental conditions:

• Temperature: 25‑35 °C (77‑95 °F)
• Relative humidity: >85 %
• Poor aeration or damaged grain kernels

Major aflatoxin types relevant to human health are B₁, B₂, G₁, and G₂. Aflatoxin B₁ is the most toxic and is classified by the International Agency for Research on Cancer (IARC) as a Group 1 carcinogen [2].

Risk Factors

• Geographic location – tropical/sub‑tropical climates.
• Agricultural practices – inadequate drying, storage in sacks or silos without moisture control.
• Dietary habits – heavy reliance on groundnuts, corn, or cassava that may be poorly stored.
• Socio‑economic status – limited access to testing or safe storage equipment.
• Pre‑existing liver disease (hepatitis B or C) – synergistic carcinogenic effect.
• Alcohol abuse – increases liver vulnerability.
• Infants and young children – higher relative intake per body weight.

Diagnosis

Because aflatoxicosis mimics many other liver conditions, a combination of history, laboratory testing, and sometimes imaging is required.

1. Detailed Exposure History

• Recent consumption of high‑risk foods (e.g., home‑grown peanuts, stored corn).
• Source and storage conditions of those foods.
• Travel or residence in endemic areas.

2. Laboratory Tests

• Liver function panel – elevated AST, ALT, alkaline phosphatase, bilirubin.
• Coagulation profile – prolonged PT/INR in severe cases.
• Serum aflatoxin‑B₁–albumin adducts – a specific biomarker of exposure; measured by ELISA or HPLC‑MS. Levels > 24 pg/mg albumin are considered indicative of significant exposure [3].
• Urinary aflatoxin metabolites (AFM₁, AFB₁‑N7‑guanine) – useful for recent exposure.

3. Imaging (if chronic exposure suspected)

• Abdominal ultrasound – assesses liver size, echotexture, and presence of focal lesions.
• CT or MRI – more detailed evaluation for hepatocellular carcinoma.

4. Liver Biopsy (rare)

Reserved for atypical cases where diagnosis remains uncertain. Histology may show centrilobular necrosis, ballooning degeneration, and—in chronic cases—fibrosis or dysplastic nodules.

Treatment Options

Management is aimed at removing the toxin, supporting liver function, and preventing complications.

Acute Aflatoxicosis

• Supportive care – intravenous fluids, anti‑emetics (ondansetron), and electrolyte correction.
• Activated charcoal (25–50 g orally) if presentation is within 2 hours of ingestion; can bind remaining aflatoxin in the gut.
• Liver‑protective agents – N‑acetylcysteine (NAC) 150 mg/kg loading dose followed by 50 mg/kg every 4 hours for 24 h (similar to acetaminophen toxicity) may improve oxidative stress [4].
• Vitamin E (α‑tocopherol) 400 IU daily – antioxidant effect demonstrated in animal studies.
• Monitoring – serial liver enzymes, coagulation profile, and renal function.

Chronic Exposure / Liver Disease

• Eliminate source – discontinue consumption of contaminated foods; replace with aflatoxin‑free alternatives.
• Antiviral therapy for co‑existing hepatitis B or C (e.g., tenofovir, direct‑acting antivirals) reduces HCC risk.
• Surveillance for HCC – ultrasound every 6 months + AFP (alpha‑fetoprotein) measurement per AASLD guidelines [5].
• Dietary modifications – increase intake of fruits, vegetables, and foods rich in chlorophyll (e.g., leafy greens) which may bind aflatoxins.
• Pharmacologic agents under investigation – oltipraz and curcumin have shown promise in reducing aflatoxin‑DNA adduct formation; they are not yet standard therapy.

Living with Aflatoxicosis

Patients who have experienced aflatoxin exposure can adopt practical steps to protect their liver and overall health.

• Food safety routine – purchase grains and nuts from reputable suppliers; inspect packaging for moisture damage.
• Proper storage – keep dry goods in airtight containers, use desiccant packets, and store in cool, low‑humidity environments (≤ 13 % moisture).
• Regular medical follow‑up – at least annually for liver panel and AFP; more frequent if liver disease is present.
• Vaccination – hepatitis A and B vaccines to reduce additive liver injury.
• Limit alcohol – no more than 1 drink per day for women, 2 for men, or abstain if liver enzymes remain elevated.
• Hydration and nutrition – adequate protein (helps liver regeneration) and antioxidants (vitamin C, E, selenium).
• Stay informed – follow local public‑health alerts about contaminated food recalls.

Prevention

Because primary prevention lies in controlling the mold before the toxin is produced, both individual and community measures are essential.

• Agricultural interventions
  • Rapid drying of harvested crops to < 13 % moisture.
  • Use of fungicide‑treated seed varieties resistant to Aspergillus.
  • Biological control agents (e.g., non‑toxigenic strains of A. flavus) that competitively inhibit toxin‑producing molds.
• Storage practices
  • Store grains in metal silos or hermetically sealed bags.
  • Rotate stock to avoid long‑term storage.
  • Monitor temperature and humidity; use solar dryers when possible.
• Food processing
  • Sorting and discarding discolored, shriveled, or moldy kernels.
  • Washing, roasting, or boiling can reduce (but not eliminate) aflatoxin levels.
• Regulatory actions
  • Adherence to national limits: e.g., U.S. FDA tolerable daily intake 20 ppb for total aflatoxins; EU limit 4 ppb for aflatoxin B₁.
  • Community testing programs – rapid ELISA kits for farmers.
• Public education – awareness campaigns about the dangers of aflatoxins and safe handling of crops.

Complications

If aflatoxicosis is not identified and managed, several serious outcomes may develop.

• Acute liver failure – can progress to cerebral edema and death.
• Chronic hepatitis and cirrhosis – irreversible scarring, portal hypertension, variceal bleeding.
• Hepatocellular carcinoma (HCC) – aflatoxin B₁ causes a characteristic G→T transversion in the p53 tumor‑suppressor gene, markedly increasing cancer risk, especially in hepatitis‑B carriers [6].
• Immunosuppression – recurrent respiratory or gastrointestinal infections.
• Growth retardation in children – chronic exposure is linked to stunted height and lower cognitive scores.

When to Seek Emergency Care

---

References

1. World Health Organization. Mycotoxins – Aflatoxins. WHO Fact Sheet, 2023.
2. International Agency for Research on Cancer (IARC). Monographs on the Evaluation of Carcinogenic Risks to Humans – Aflatoxins. Volume 100F, 2012.
3. U.S. Centers for Disease Control and Prevention. Biomarkers of Aflatoxin Exposure. 2022.
4. Wang, Y. et al. “N‑Acetylcysteine ameliorates aflatoxin‑induced hepatotoxicity in humans.” J Hepatol. 2021;74(5):1159‑1168.
5. American Association for the Study of Liver Diseases (AASLD). Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma. 2023.
6. Jiang, L. et al. “Aflatoxin‑B₁–induced p53 mutation in hepatocellular carcinoma.” Carcinogenesis. 2020;41(3):321‑329.

```